↓ Skip to main content

Cochrane Database of Systematic Reviews

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension

Overview of attention for article published in Cochrane database of systematic reviews, January 2010
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
twitter
3 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
73 Mendeley
citeulike
1 CiteULike
Title
Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension
Published in
Cochrane database of systematic reviews, January 2010
DOI 10.1002/14651858.cd007185.pub2
Pubmed ID
Authors

Jenny MH Chen, Balraj S Heran, Marco I Perez, James M Wright

Abstract

Beta-blockers are one of the more commonly prescribed classes of anti-hypertensive drugs, both as first-line and second-line.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
United Kingdom 1 1%
Colombia 1 1%
Unknown 70 96%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 15%
Student > Master 11 15%
Researcher 10 14%
Student > Ph. D. Student 8 11%
Student > Postgraduate 6 8%
Other 14 19%
Unknown 13 18%
Readers by discipline Count As %
Medicine and Dentistry 37 51%
Nursing and Health Professions 6 8%
Biochemistry, Genetics and Molecular Biology 4 5%
Agricultural and Biological Sciences 4 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Other 4 5%
Unknown 16 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2020.
All research outputs
#4,415,058
of 16,575,021 outputs
Outputs from Cochrane database of systematic reviews
#6,947
of 11,536 outputs
Outputs of similar age
#39,839
of 158,806 outputs
Outputs of similar age from Cochrane database of systematic reviews
#61
of 116 outputs
Altmetric has tracked 16,575,021 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 11,536 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 158,806 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.